Zinc finger protein 384 (ZNF384) impact on childhood mixed phenotype acute leukemia and B-cell precursor acute lymphoblastic leukemia

References

• Goroshchuk O, Kolosenko I, Vidarsdottir L, et al. Polo-like kinases and acute leukemia. Oncogene 2019;38(1):1–16.
   PubMed Web of Science ®Google Scholar
• Ping N, Qiu H, Wang Q, et al. Establishment and genetic characterization of a novel mixed-phenotype acute leukemia cell line with EP300-ZNF384 fusion. J Hematol Oncol. 2015;8:100.
   PubMed Web of Science ®Google Scholar
• Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the world health organization classification of myeloid neoplasms and acute leukemia. Blood 2016;127(20):2391–2405.
   PubMed Web of Science ®Google Scholar
• Bhojwani D, Yang JJ, Pui CH. Biology of childhood acute lymphoblastic leukemia. Pediatr Clin North Am. 2015;62(1):47–60.
   PubMed Web of Science ®Google Scholar
• Terwilliger T, Abdul-Hay M. Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J. 2017;7(6):e577.
   PubMed Web of Science ®Google Scholar
• Stary J, Zuna J, Zaliova M. New biological and genetic classification and therapeutically relevant categories in childhood B-cell precursor acute lymphoblastic leukemia. F1000Res. 2018;7:1569.
   Google Scholar
• Hirabayashi S, Ohki K, Nakabayashi K, Tokyo Children’s Cancer Study Group (TCCSG), et al. ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype. Haematologica 2017;102(1):118–129.
   PubMed Web of Science ®Google Scholar
• Lilljebjorn H, Fioretos T. New oncogenic subtypes in pediatric B-cell precursor acute lymphoblastic leukemia. Blood 2017;130(12):1395–1401.
   PubMed Web of Science ®Google Scholar
• Iacobucci I, Mullighan CG. Genetic basis of acute lymphoblastic leukemia. J Clin Oncol. 2017;35(9):975–983.
   PubMed Web of Science ®Google Scholar
• Qian M, Zhang H, Kham SK, et al. Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP. Genome Res. 2017;27(2):185–195.
   PubMed Web of Science ®Google Scholar
• Alexander TB, Gu Z, Iacobucci I, et al. The genetic basis and cell of origin of mixed phenotype acute leukaemia. Nature 2018;562(7727):373–379.
   PubMed Web of Science ®Google Scholar
• McClure BJ, Heatley SL, Kok CH, et al. Pre-B acute lymphoblastic leukaemia recurrent fusion, EP300-ZNF384, is associated with a distinct gene expression. Br J Cancer. 2018;118(7):1000–1004.
   PubMed Web of Science ®Google Scholar
• He L, Fan X, Li Y, et al. Overexpression of zinc finger protein 384 (ZNF 384), a poor prognostic predictor, promotes cell growth by upregulating the expression of cyclin D1 in hepatocellular carcinoma. Cell Death Dis. 2019;10(6):444.
   PubMedGoogle Scholar
• Crans HN, Sakamoto KM. Transcription factors and translocations in lymphoid and myeloid leukemia. Leukemia 2001;15(3):313–331. Mar
   PubMed Web of Science ®Google Scholar
• Shago M, Abla O, Hitzler J, et al. Frequency and outcome of pediatric acute lymphoblastic leukemia with ZNF384 gene rearrangements including a novel translocation resulting in an ARID1B/ZNF384 gene fusion. Pediatr Blood Cancer. 2016;63(11):1915–1921.
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Kawamoto S, Mizutani Y, et al. Mixed phenotype acute leukemia with t(12;17)(p13;q21)/TAF15-ZNF384 and other chromosome abnormalities. Cytogenet Genome Res. 2016;149(3):165–170.
   PubMed Web of Science ®Google Scholar
• Law WJ, Cann KL, Hicks GG. TLS, EWS and TAF15: a model for transcriptional integration of gene expression. Brief Funct Genomic Proteomic. 2006;5(1):8–14.
   PubMedGoogle Scholar
• Patel D, Chinaranagari S, Chaudhary J. Basic helix loop helix (bHLH) transcription factor 3 (TCF3, E2A) is regulated by androgens in prostate cancer cells. Am J Cancer Res. 2015;5(11):3407–3421.
   PubMed Web of Science ®Google Scholar
• Dickerson K, Yoshihara H, Janke L, et al. Expression of TCF3-ZNF384 in human hematopoietic cells induces lineage disruption in vitro and acute leukemia in vivo. Blood 2018;132(Supplement 1):550–550.
   Google Scholar
• Dworzak MN, Buldini B, Gaipa G, International-BFM-FLOW-network, et al. AIEOP-BFM consensus guidelines 2016 for flow cytometric immunophenotyping of pediatric acute lymphoblastic leukemia. Cytometry B Clin Cytom. 2018;94(1):82–93.
   PubMed Web of Science ®Google Scholar
• Pomerantz A, Rodriguez-Rodriguez S, Demichelis-Gomez R, et al. Mixed-phenotype acute leukemia: suboptimal treatment when the 2008/2016 WHO classification is used. Blood Res. 2016;51(4):233–241.
   PubMed Web of Science ®Google Scholar
• Charles NJ, Boyer DF. Mixed-Phenotype acute leukemia: diagnostic criteria and pitfalls. Arch Pathol Lab Med. 2017;141(11):1462–1468.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Yaguchi A, Ishibashi T, Terada K, et al. EP300-ZNF384 fusion gene product up-regulates GATA3 gene expression and induces hematopoietic stem cell gene expression signature in B-cell precursor acute lymphoblastic leukemia cells. Int J Hematol. 2017;106(2):269–281.
   PubMed Web of Science ®Google Scholar
• Blobel GA. CREB-binding protein and p300: molecular integrators of hematopoietic transcription. Blood 2000;95(3):745–755.
   PubMed Web of Science ®Google Scholar
• Pasqualucci L, Dominguez-Sola D, Chiarenza A, et al. Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature 2011;471(7337):189–195.
   PubMed Web of Science ®Google Scholar
• Patel D, Chaudhary J. Increased expression of bHLH transcription factor E2A (TCF3) in prostate cancer promotes proliferation and confers resistance to doxorubicin induced apoptosis. Biochem Biophys Res Commun. 2012;422(1):146–151.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Wang F, Morita K, et al. Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes. Nat Commun. 2018;9(1):2670.
   Google Scholar
• Wolach O, Stone RM. How I treat mixed-phenotype acute leukemia. Blood 2015;125(16):2477–2485.
   PubMed Web of Science ®Google Scholar
• Weinberg OK, Arber DA. Mixed-phenotype acute leukemia: historical overview and a new definition. Leukemia 2010;24(11):1844–1851.
   PubMed Web of Science ®Google Scholar
• Hirabayashi S, Butler ER, Ohki K, et al. Clinical characteristics and outcomes of B-ALL with ZNF384 rearrangements: a retrospective analysis by the ponte di legno childhood ALL working group. Leukemia 2021;35(11):3272–3277.
   PubMed Web of Science ®Google Scholar
• Kim JE, Woo KS, Kim KE, et al. A rare case of acute lymphoblastic leukemia with t(12;17)(p13;q21). Korean J Lab Med. 2010;30(3):239–243.
   PubMedGoogle Scholar
• Liu HW, Wan SK, Ching LM, et al. Translocation (12 17)(P11-12 Q11-12) - a recurrent primary rearrangement in Acute-Leukemia. Cancer Genet Cytogen. 1992;64(1):27–29.
   PubMedGoogle Scholar
• Asahara SI, Saigo K, Hasuike N, et al. Acute lymphoblastic leukemia accompanied by chromosomal abnormality of translocation (12;17). Haematologia (Budap). 2001;31(3):209–213.
   PubMedGoogle Scholar
• Reid AG, Seppa L, von der Weid N, et al. A t(12;17)(p13;q12) identifies a distinct TEL rearrangement-negative subtype of precursor-B acute lymphoblastic leukemia. Cancer Genet Cytogenet. 2006;165(1):64–69.
   PubMedGoogle Scholar
• Al-Shehhi H, Konn ZJ, Schwab CJ, et al. Abnormalities of the der(12)t(12;21) in ETV6-RUNX1 acute lymphoblastic leukemia. Genes Chromosomes Cancer. 2013;52(2):202–213.
   PubMed Web of Science ®Google Scholar
• Novakova M, Zaliova M, Fiser K, et al. DUX4r, ZNF384r and PAX5-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switch. Haematologica 2021;106(8):2066–2075.
   PubMed Web of Science ®Google Scholar